Medpace has historically shown incredible growth and strong return metrics. It is currently down 35% from its ATH. Read more ...

We purchased shares of Icon in March 2024 for ~$323.00 per share. Why did we sell our ICLR position and move on? Click here ...

CROX is positioned for sustainable growth, fueled by strong consumer demand, strategic initiatives and expanding brand ...

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are ...

Good day, ladies and gentlemen, and welcome to the Levi Strauss & Company First Quarter Fiscal 2025 Earnings Conference Call ...

Tesla shares might be trading under $300 and well off their record. However, they still don't look like a compelling buying ...

Duggan pointed to lowering unemployment rates, boosting public safety, and growing revenue. The third-term mayor also praised ... The mayor also touted Detroit's income tax growth, which the ...

Q4 2024 Earnings Call Transcript April 1, 2025 Operator: All sites on hold. We do appreciate your patience in holding and ask ...

As global inequality soars, President Donald Trump has recruited a bloat of fellow billionaires to help run his ...

Bengaluru-based Hypergro automates video generation, optimises performance campaigns, and engages leads through AI-powered ...

Donald Trump has announced tariffs on imports from countries around the world. Is it a good move for America? Our writers' verdicts—plus have your say.

OLIPOP CEO Ben Goodwin discusses the past, present, and future of the prebiotic soda brand as it’s reached a $1.85 billion valuation.